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A hybrid construct derived from ovine trophoblastin cDNA and bovine ~-~actalbumin~ncod~ng gene. was injected into the pronuclei of mouse 
epss. In one of the resulting transgenic mouse lines, expression of the hybrid construct was detected and found to be Iimited to the mammary 
gland of lactating females which secreted active ovine trophoblastin. This strongly suggests that important &-acting DNA sequences involved 
in tissue-specific expression of the bovine gene are located within the second half of the 3’ untranslated region, or/and the proximal 5’ and 3’ regions 
flanking the transcriptional unit. 
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I. INTRODUCTION 
The entire bovine ~-1actaIbumin (bcuLa) gene and the 
flanking DNA sequences have been isolated and charac- 
terized in our laboratory [I]. Expression of this gene in 
several lines of transgenic mice was stage- and tissue- 
specific, and in two of them, the yield of bmLa in milk 
was close to that of its endogenous counterpart 121, in- 
dicating the occurrence of &-acting mammary regufa- 
tory elements within the transgene. Promoter sequences 
of various milk protein genes including,&lactoglobulin, 
whey acidic protein (WAP), ,& and asl-casein have 
been used to direct expression of foreign proteins in the 
mammary gland of transgenic mice (see [33 for review). 
2. MATERIALS AND METHODS 
2. I . ~a[eri~ls 
All enzymes, RNase protection kit and oligo-lab~llin8 kit were pur- 
chased from Boehringer Mannheim. [a-“P]dCTP was obtained from 
Amersham. Other chemicals came either from Sigma or Poly-labo. 
2.2. Esrablishnenr of the hybrid constnrcr 
A 3.2 kb HindllI/PsfI genomic fragment comprising the barLa 
transcriptlon unit with 740 bp and 450 bp of 5’- and 3’-flanking 
region [l], respectively. was cloned into the corresponding sites of the 
pPolyIll-I poly-linker [5]. Most of the transcription unit of the bovine 
gene was excised, leaving only IS3 bp of the 3’ untranslated region, 
and replaced by the oTP cDNA, ihortened of 60 bp at the 3’ end [6], 
as illustrated in Fig. I. The 2.3 kb insert was released by digestion with 
X/rot and purified as already described [2]. 
2.3. micro-injectio~l, trartsfer of mouse eggs and idet~r~~cu~ion of In order to demonstrate the potential usefulness of 
the blrLa promoter for driving the expression of a link- 
ed gene in mamamary gland, the ovine trophoblastin 
(oTP) cDNA was chosen as reporter, since this aII-like 
interferon (IFN-crII) can be detected and quantified 
easily. Trophoblast proteins play a major role in the 
establishment of pregnancy in ruminants by blocking 
the pulsatile secretion of prostaglandin Fzcr by the 
uterus and thereby ensuring the maintenance of the cor- 
pus luteum function (see (41 for review), 
trarisyenic mice 
.Microinjection was performed on pronuclei of (CS7BL/6 x CBA) 
Ft hybrid eggs [7]: 1041 eggs were each injected with approximatively 
200 copies of the linearized hybrid gene and re-implanted into 
pseudopregnant recipient mice; 66 mice were born, of which 20 died 
accidentally soon after birth (cannibalism, death of foster mothers). 
Transgenic mice were identified by Southern analysis of their genomic 
DNA as described in 121 and illustrated in Fig. 2. 
2.4, RNA isolarion and analysis 
Total RNA was isolated after homogenization 01 tissues in a 
guanidium thiocyanate solution as described in [8]. RNase protection 
was performed according to Sambrook et al, IS] and as illustrated in 
Fig. 3. 
Carres//otrde/rce m/dress: J.L. Vi!o!te, Lahoratoire de Physiolo8ie 
Cornpar&, UnivcrsitP Paris VI , 2 place Jussieu. 75005 Paris, France 
2.5. Milk protein analssis 
Milk was collected from nursing mice, I2 days aflcr parruririon as 
previously described [IO]. Milk samples were defatted by centrifuga- 
rl bhrcvin/iorrs: bmLa I bovine n-lectalbrrmin; oTP, ovine lion after a I/S dilution in distilled water 121, and tested in an antiviral 
tropl~oblastil~: IFN, intcrfcron interferon bioassay based on protection against cyropathio cffccts of 
Volume 284, number I FEBSLETTERS June 1991 
A. B. 
EindiII PSiI PStiFSti 
GTGGTGACCCCATT CTGGGCCCTG 
3StZEII Apa 
1 
EcoRI ssp1 
c. 
Hind111 PstfPstI Pstr 
GTGGTGAC S&fiES!@ GGCC aTTAb 500 bp 
Fig. 1. Construction of the hybrid gene. A. Structure of the baLa gene: white, black, hatched and grey segments represent 5’ or 3’ flanking regions, 
the coding frame, introns and 5 ‘ or 3’ untranslated regions, respectively. Positions and sequences of the two restriction sites, used to remove part 
of the transcription unit, are indicated below (bold-faced nucleotides refer to the 5’-flanking region, recognition sites are underlined and cutting 
sites are indicated by arrows). B. Structure of the oTP cDNA: light-grey and striped segments represent he 5’ or 3’ untranslated regions and the 
coding frame, respectively. Positions and sequences of the two restriction sites used for inserting the eDNA between the two brula-derived 
fragments are indicated below (the EcoRi site is part of the linker used for cDNA cloning [6], recognition sites are underlined and cutting sites 
indicated by arrows). C. Structure of the hybrid gene. All fragments were end-blunted before ligation. Sequences of ligation sites are indicated 
below. The arrow indicates the new potential CAP site. 
Fig. 2. Characterization of transgenic mice by Southern blot analysis, 
Southern blot experiments were carried OUI on WI-digested genomic 
DNA as described in 121. Right margin: (A) rcstriclion fragments 
derived from cndogenous IFN-related sequences; (B) I,1 kb WI 
rcslriction fragments corresponding to the 3 ’ end of the trnnsgenc and 
to its 5’ end in the case of tttultiple copies arrt~t!~ed in a Ilead-to.tail 
fashion (SW Fig. 1); (C) 200 bp internal Psfl fragment from the 
tranrgcne. Left margin: ~~Nkdlll/EcoRI size markers. Lane T: 
lincarizcd transgcne in amount equivalent 10 1 copy per cell, lane 1: 
DNA front non-trmsycnic mire. lane 2: DNA from transgcnic 
offspring of founder Morse 33, lane 3: DNA from transpcnic 
offspring of founder II~SC 13. In lanes 2 and 3, hybridizing 
fr~~ll~el~ts, other than !hose tnc~~ti~~~ed above, might correspond to 
junction fr;lgmcfits. 
20 
vesicular stomatitis virus (VW) on Madin Darby Bovine Kidney 
(MDBK) cells [I I]+ IFN titers were calculated relative to that of a por- 
cine IFN-al standardized with human reference IFN Nlki, GA, 
23 902 530 (NIH Bethesda MD) [12]. 
3. RESULTS 
3-i . Generation of transgenic mice 
Eight transgenic mice, including three femaIes, 13, 24 
and 33, were detected out of the 46 screened by 
Southern analysis of their tail-purified genomic DNA 
(Fig. 2 and Table I). MuItiple copies, ranging from 2 to 
around 20, were arranged in a head-to-tail fashion. Un- 
fortunateIy, two founder mice, 21 and 24, died before 
giving birth to any transgenic offspring, one, 43, was 
found to be sterile nnd only four out of five left 
transmitted the transgene to their offspring. None of 
those had multipte integration sites as judged from 
Southern blotting DNA analysis of their progeny. 
3.2. Expressiort of the transgene 
Expression of the transgene was only found in the 
mammary gland of lactating transpenic offspring of 
founder mouse 13: specific RNAs were detected in 
mammary tissue by RNase protection (Fig. 3) and an in- 
terferonic activity of about 20~000 U/ml was found in 
milk samples (Table I), which corresponds to an oTP 
concentration close to 1 ~~g/ml, assuming an IFN activi- 
ty of 2-3.10’ U/mg of 0TP [13]. 
4. Discussion 
Mammary tissue-specific expression of both the en- 
tire baLa gene [t] and the derived hybrid gene indicates 
that some, if not all relevant c/s-acting DNA elements 
Volume 254, number 1 FEBS LETTERS June 1991 
Table 1 
Summary of transgene expression in the different lines 
Line Copies 
integrated 
Transmission 
founder mice 
Integration 
sites 
Multiple copies 
arrangement 
Expression in transgenic offsprings 
mRNA/Tissue Protein in the 
soecificitv milk (U/ml) 
13 
19 
21 
24 
26 
33 
36 
43 
Mouse 
05 
15 
02 
10 
15 
20 
20 
05 
2/14 (14.3%) 1 head-to-tail 
7116 (43.7%) I head-to-tail 
O/6 n-d. head-to-tail 
n.d. n-d. head-to-tail 
O/36 10%) n.d. head-to-tail 
S/I2 (41.6%) 1 head-to-tail 
2/2 (100%) I head-to-tail 
Sterile n.d. head-to-tail 
yes/yes 
no 
n.d. 
n.d. 
n.d. 
no 
no 
n.d. 
-200000 
0 
n.d. 
n.d. 
n.d. 
0 
0 
n.d. 
0 
Numbers of integrated copies were estimated with internal standards as described in [2]. n.d., not determined; no, undetectable levels. Protein 
concentrations were estimated as described in Section 2. - : about. 
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Fig. 3. Transcript analysis by RNase protection. Each sample 
contained 20 qg of RNA extracted from: lactafing mammary gland 
(lane A) and liver (B) flom a non-transgenic mouse; day IG sheep 
embryo (C); lactating mammary glands (D,E), liver (F), spleen (G) 
and salivary gland (H) from transgenic offspring of founder mouse 
13; lactating mammary glands from transgenic offspring of founder 
mice 19 (I), 33 (J) and 36 (K); testes (L), liver (M), spleen (N) and 
salivary gland (0) from transgcnic offspring of founder mouse 13. 
Sizes of the protcctcd fragments, calculated from a sequencing 
ladder, are indicated on the right margin. Location of the 950 b 
antiscnsc-RNA probe rclativc to tltc transgcnc is indicated below. The 
probe corresponds IO the transcription of the 950 bp PsrI/HirrclIll 
fragment. A. 3’-End of the 207 b protcctcd fragnicnt with RNA from 
day-16 sheep embryos (used as internal standard): this fragment 
cstcnds from the &/I site to the 5’-end of the oTP cDNA, ns 
indicated. B. 3’-End of the 2i2 b protcctcd fragment with RNA from 
lactating mammary gland of transgcnic offspring of founder mouse 
13: this frapmcnt cstcnds from the IJ.r/l site to the indicated base, 
dctcrmiiicd according to its Icngth. 
involved in the process are located at least in ot?e of the 
following parts of the baLa gene: the 750 bp 5 ’ and 450 
bp 3’ regions flanking the transcriptional unit, and 
possibly the second half of the 3’ untranslated region. 
However, since only one transgenic line expressed the 
hybrid transgene, a possible influence of the integration 
site on tissue distribution, although unlikely, cannot be 
formely ruled out. 
All six transgenic lines previously obtained [2] ex- 
pressed the b@La transgene, two of them at a high level, 
whereas three out of four lines carrying the hybrid 
transgene did not produce any detectable level of oTP 
mRNA. Such a difference in expression may result 
from the lack of intron in the hybrid. Similar discrepan- 
cies were observed in other experiments involving the 
WAP gene and intronless derived constructs [14-171. 
Furthermore, the importance of introns on the 
transcriptional efficiency in transgenic mice was recent- 
ly reported [l&19]. However, the use of sequences 
derived from an intronless gene was shown to confer an 
intron-independant expression in vitro [20]. 
Other factors might affect the level of expression: (i) 
the integration site, as already observed with the entire 
baLa gene [2]; (ii) the occurrence of important cis- 
acting DNA sequences, involved in this regulation, 
within the transcription unit of the bovine gene; (iii) the 
2 bp deletion between the TATA-box and the Cap site 
in the construct (Figs. 1 and 3), although this does not 
affect the transcriptiona efficiency in vitro [21]; (iv) the 
occurrence of AU-rich sequences recognized by a 
cytosolic protein [22] within the 3’-untranslated region 
of the oTP cDNA, which are responsible, in part, for 
the susceptibility of many mRNAs to cytoplasmic in- 
stability (see [23] for review). 
Expression of oTP in line 13 does not apparently af- 
fect growth of offspring and fertility of mice. It has 
been reported chat interferon expression in the testes of 
transgcnic mice leads to male sterility [24). It is possible, 
but yet to be confirmed, that the sterility of male43 was 
clue to the expression of the transgenc in tha! tissue. 
21 
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However, using other constructs derived from the baLa 
gene, we have also observed similar Go sterile males 
(data not shown). 
Secretion of miscellaneous foreign proteins, such as 
human al-antitrypsin, antihemophilic factor IX, 
interleukin-2, urokinase, tissue plasminogen activator, 
CD4 protein and growth hormone, in milk of trans- 
genie animals carrying constructs derived from milk 
protein-encoding genes have already been reported 
[15,25-271 (see [3] for review), and the present study, 
using very short sequences of the baLa gene, provides 
another example of the potential of structural elements 
of milk prctein genes to direct expression of hybrid 
transgenes in the mammary gland. We are currently 
working on other constructs to try to define more 
precisely the DNA sequences involved in mammary 
tissue-specific expression of the baLa gene and to im- 
prove expression of recombinant proteins. 
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